RecruitingNCT06740396

Prevalence and Severity of Depression in Coronary Artery Disease Patients

Assessing the Prevalence and Severity of Depression Among Coronary Artery Diseases Patients in Baghdad Using the PHQ-9: A Cross-Sectional Study

Sponsor

Al-Nahrain University

Enrollment

200 participants

Start Date

Feb 20, 2025

Study Type

OBSERVATIONAL

Conditions

Depression - Major Depressive Disorder

Summary

This observational study aims to estimate the prevalence and severity of depression among patients with coronary artery disease (CAD) in Baghdad, Iraq, using the self-administered PHQ-9 questionnaire. The study seeks to answer the following questions: What is the prevalence of depression among CAD patients? How is the severity of depression distributed within this group? Are specific demographic, clinical, or environmental factors associated with higher levels of depression? Participants will: Complete the PHQ-9 to assess the severity of depressive symptoms at a specific point in time. Provide demographic and clinical information, including age, gender, socioeconomic status, comorbidities, and CAD-related factors such as type of intervention and duration of illness, to explore potential correlations with depression.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study measures how common and how severe depression is in patients with coronary artery disease (blockages in the heart's blood vessels) at hospitals in Baghdad. Depression is often underdiagnosed in heart patients even though it significantly affects recovery and quality of life. **You may be eligible if...** - You have been diagnosed with coronary artery disease confirmed by clinical, imaging, or procedural evidence - You are receiving care at one of the designated hospitals in Baghdad - You are able to complete a standard depression questionnaire (PHQ-9) on your own or with minimal help - You consent to participate in the study **You may NOT be eligible if...** - You have a history of severe psychiatric disorders unrelated to depression (such as schizophrenia or bipolar disorder) - You have cognitive impairment or a neurological condition that prevents you from completing the questionnaire - You are already being treated for depression Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.